Skip Navigation



Carcinogenesis Advance Access published online on March 28, 2003
Carcinogenesis, doi:10.1093/carcin/bgg045
© 2003 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
24/6/1149    most recent
bgg045v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by McFarlin, D. R.
Right arrow Articles by Gould, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McFarlin, D. R.
Right arrow Articles by Gould, M. N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

CARCINOGENESIS

Rat mammary carcinogenesis induced by in situ expression of constitutive Raf kinase activity is prevented by tethering Raf to the plasma membrane

Daniel R. McFarlin 1 Michael N. Gould 1*

1 McArdle Laboratory for Cancer Research, University of Wisconsin--Madison 53706

* Corresponding author. E-mail: gould{at}oncology.wisc.edu.

Received 18 September 2002 ; revised 5 March 2003 ; accepted 8 March 2003

Abstract

Mammary carcinogenesis induced through expression of activated Raf was investigated using a model in which retroviral vectors were infused into the central ducts of rat mammary glands. This model allows efficient expression of experimental proteins in a small fraction of endogenous mammary epithelial cells in situ. We previously reported that Raf is the dominant oncogenic signaling pathway from activated Ras in rat mammary glands. We show here that mammary gland carcinogenesis is rapidly induced by the expression of c-Raf-1 kinase that is activated by n-terminal truncation ({Delta}-Raf). Interestingly, targeting Raf to the plasma membrane via c-terminal fusion with Ras membrane localization signals (Raf-Caax) induces Raf kinase activity that transforms 3T3 cells more frequently than {Delta}-Raf, yet in situ expression of Raf-Caax does not induce mammary carcinomas. To investigate these contrasting results and begin elucidating the mechanisms of Raf induced mammary carcinogenesis; we combined both activating mutations (n-terminal truncation and c-terminal membrane localization motifs) in one Raf construct ({Delta}-Raf-Caax). While {Delta}-Raf-Caax transforms 3T3 cells more efficiently than {Delta}-Raf or Raf-Caax, in situ expression of {Delta}-Raf-Caax does not induce carcinomas in vivo, demonstrating that lipid modification on the c-terminus of {Delta}-Raf negates its oncogenic potential in rat mammary gland.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
S. Murata, S. L. Kominsky, M. Vali, Z. Zhang, E. Garrett-Mayer, D. Korz, D. Huso, S. D. Baker, J. Barber, E. Jaffee, et al.
Ductal Access for Prevention and Therapy of Mammary Tumors
Cancer Res., January 15, 2006; 66(2): 638 - 645.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Beeram, A. Patnaik, and E. K. Rowinsky
Raf: A Strategic Target for Therapeutic Development Against Cancer
J. Clin. Oncol., September 20, 2005; 23(27): 6771 - 6790.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.